Biologics, Small Molecules and More in Inflammatory Bowel Disease: The Present and the Future

Inflammatory bowel disease (IBD) is a group of heterogeneous chronic inflammatory diseases of the gut presenting with intestinal and extraintestinal manifestations. Most cases fit in predominantly two types, namely, ulcerative colitis and Crohn’s disease. The incidence of IBD has been increasing ste...

Full description

Bibliographic Details

Published in:	Future Pharmacology
Main Authors:	Manish Manrai, Atul Abhishek Jha, Saurabh Dawra, Aditya Vikram Pachisia
Format:	Article
Language:	English
Published:	MDPI AG 2024-03-01
Subjects:	inflammatory bowel disease ulcerative colitis Crohn’s disease anti-TNF infliximab adalimumab
Online Access:	https://www.mdpi.com/2673-9879/4/1/17